Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
By Josh BeckermanActuate Therapeutics' stock slid after the cancer drug developer disclosed plans to sell 50 million shares, which would increase its outstanding shares to 74 million.The stock was down 22% to 63 cents after hours. As of the market close, shares were down 87% year to date.Actuate ex…
By Josh Beckerman Actuate Therapeutics' stock slid after the cancer drug developer disclosed plans to sell 50 million shares, which would increase its outstanding shares to 74 million. The stock was down 22% to 63 cents after hours. As of the market close, shares were down 87% year to date. Actuate expects to use proce